Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
10 resultados
Method and composition for treating prostate cancer
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention is directed to a method for treating prostate cancer by administering collagenase alone or in combination with a glycosidase, a protease, a nuclease, a lipase, an esterase, a streptokinase, or a combination thereof. A typical embodiment includes
Method and composition for treating prostate cancer
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention is directed to a method for treating prostate cancer by administering collagenase alone or in combination with a glycosidase, a protease, a nuclease, a lipase, an esterase, a streptokinase, or a combination thereof. A typical embodiment includes
Methods and compositions related to targeting monoacylglycerol lipase
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
COPYRIGHT NOTIFICATION
Pursuant to 37 C.F.R. .sctn.1.71(e), Applicants note that a portion of this disclosure contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or patent disclosure, as it
Method for treatment of cachexia by administering inhibitors of adipose triglyceride lipase expression or activity
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to methods of prevention, treatment or alleviation of cachexia and other wasting syndromes or conditions of loss of weight and/or muscle atrophy by modulation, including inhibition, of lipase, particularly adipose triglyceride lipase (ATGL). The
Tumor specific delivery of therapeutic agents via liposomase
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
TECHNICAL FIELD OF THE INVENTION
This invention is related to the area of oncology. In particular, it relates to treatment of tumors which enhance the selective toxicity of anti-cancer agents.
BACKGROUND OF THE INVENTION
There is no dearth of drugs that can kill cancer cells. The challenge is
Tumor-specific delivery of therapeutic agents via liposomase
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
TECHNICAL FIELD OF THE INVENTION
This invention is related to the area of oncology. In particular, it relates to treatment of tumors which enhance the selective toxicity of anti-cancer agents.
BACKGROUND OF THE INVENTION
There is no dearth of drugs that can kill cancer cells. The challenge is
Tumor-specific delivery of therapeutic agents via liposomase
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
TECHNICAL FIELD OF THE INVENTION
This invention is related to the area of oncology. In particular, it relates to treatment of tumors which enhance the selective toxicity of anti-cancer agents.
BACKGROUND OF THE INVENTION
There is no dearth of drugs that can kill cancer cells. The challenge is
ABHD6 and dual ABHD6/MGL inhibitors and their uses
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND
Cannabinoid receptors, CB1 and CB2, are part of the endocannabinoid system (ECS), which consists of cannabinoid receptors, endogenous endocannabinoids anandamide (AEA) and 2-arachindonoylglycerol (2-AG) and the hydrolytic enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol
Pharmaceuticals and assays using enzyme subunits
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The present invention relates to methods for releasing an agent under pre-determined conditions. for example at a predetermined site or in the presence of a pre-determined material. and in particular for releasing an agent for therapeutic. diagnostic or investigative purposes The invention further
Resveratrol polymerization compound or pharmaceutically acceptable salt thereof
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
TECHNICAL FIELD
The present invention relates to a novel resveratrol polymerization compound or a pharmaceutically acceptable salt thereof and a method for manufacturing the same and relates to foods, pharmaceutical agents, quasi drugs, or cosmetics containing the resveratrol polymerization compound
O mais completo banco de dados de ervas medicinais apoiado pela ciência
- Funciona em 55 idiomas
- Curas herbais apoiadas pela ciência
- Reconhecimento de ervas por imagem
- Mapa GPS interativo - marcar ervas no local (em breve)
- Leia publicações científicas relacionadas à sua pesquisa
- Pesquise ervas medicinais por seus efeitos
- Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes
Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas
